Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Tax Provisions (2018 - 2025)

Tandem Diabetes Care's Tax Provisions history spans 8 years, with the latest figure at $5.2 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 803.09% year-over-year to $5.2 million; the TTM value through Dec 2025 reached $4.4 million, up 6.76%, while the annual FY2025 figure was $4.4 million, 6.81% up from the prior year.
  • Tax Provisions reached $5.2 million in Q4 2025 per TNDM's latest filing, up from -$4.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $8.5 million in Q1 2025 to a low of -$5.3 million in Q2 2025.
  • Average Tax Provisions over 5 years is $648300.0, with a median of $312000.0 recorded in 2021.
  • The largest YoY upside for Tax Provisions was 2901.85% in 2022 against a maximum downside of 1373.5% in 2022.
  • A 5-year view of Tax Provisions shows it stood at $337000.0 in 2021, then tumbled by 176.56% to -$258000.0 in 2022, then tumbled by 420.54% to -$1.3 million in 2023, then surged by 44.53% to -$745000.0 in 2024, then surged by 803.09% to $5.2 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Tax Provisions are $5.2 million (Q4 2025), -$4.0 million (Q3 2025), and -$5.3 million (Q2 2025).